nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—CYP2D6—Gefitinib—lung cancer	0.0811	0.32	CbGbCtD
Labetalol—CYP2D6—Vinorelbine—lung cancer	0.0625	0.246	CbGbCtD
Labetalol—CYP2D6—Erlotinib—lung cancer	0.048	0.189	CbGbCtD
Labetalol—CYP2D6—Vinblastine—lung cancer	0.0385	0.152	CbGbCtD
Labetalol—CYP2D6—Doxorubicin—lung cancer	0.0237	0.0933	CbGbCtD
Labetalol—Formoterol—CYP2A6—lung cancer	0.00214	0.148	CrCbGaD
Labetalol—Arformoterol—CYP2A6—lung cancer	0.00214	0.148	CrCbGaD
Labetalol—Flurbiprofen—UGT1A1—lung cancer	0.00166	0.115	CrCbGaD
Labetalol—Ketoprofen—CXCL8—lung cancer	0.00141	0.0979	CrCbGaD
Labetalol—Mirabegron—ALB—lung cancer	0.00104	0.0722	CrCbGaD
Labetalol—Mirabegron—ABCB1—lung cancer	0.000995	0.0689	CrCbGaD
Labetalol—Salsalate—PTGS2—lung cancer	0.000846	0.0586	CrCbGaD
Labetalol—Isoprenaline—CYP1A1—lung cancer	0.000805	0.0557	CrCbGaD
Labetalol—Fenoprofen—PTGS2—lung cancer	0.000699	0.0484	CrCbGaD
Labetalol—Fenoprofen—ALB—lung cancer	0.000623	0.0431	CrCbGaD
Labetalol—Loss of consciousness—Paclitaxel—lung cancer	0.000572	0.000906	CcSEcCtD
Labetalol—Hyperhidrosis—Cisplatin—lung cancer	0.000572	0.000905	CcSEcCtD
Labetalol—Paraesthesia—Gemcitabine—lung cancer	0.00057	0.000902	CcSEcCtD
Labetalol—Asthenia—Vinorelbine—lung cancer	0.000567	0.000897	CcSEcCtD
Labetalol—Dyspnoea—Gemcitabine—lung cancer	0.000566	0.000895	CcSEcCtD
Labetalol—Nausea—Vinblastine—lung cancer	0.000565	0.000894	CcSEcCtD
Labetalol—Somnolence—Gemcitabine—lung cancer	0.000564	0.000893	CcSEcCtD
Labetalol—Affect lability—Doxorubicin—lung cancer	0.000563	0.000891	CcSEcCtD
Labetalol—Hypertension—Paclitaxel—lung cancer	0.000562	0.00089	CcSEcCtD
Labetalol—Fatigue—Irinotecan—lung cancer	0.000562	0.000889	CcSEcCtD
Labetalol—Alopecia—Docetaxel—lung cancer	0.00056	0.000886	CcSEcCtD
Labetalol—Pruritus—Vinorelbine—lung cancer	0.000559	0.000884	CcSEcCtD
Labetalol—Discomfort—Etoposide—lung cancer	0.000558	0.000884	CcSEcCtD
Labetalol—Pain—Irinotecan—lung cancer	0.000557	0.000882	CcSEcCtD
Labetalol—Constipation—Irinotecan—lung cancer	0.000557	0.000882	CcSEcCtD
Labetalol—Mental disorder—Docetaxel—lung cancer	0.000555	0.000879	CcSEcCtD
Labetalol—Hypotension—Cisplatin—lung cancer	0.000553	0.000875	CcSEcCtD
Labetalol—Erythema—Docetaxel—lung cancer	0.000552	0.000873	CcSEcCtD
Labetalol—Nausea—Topotecan—lung cancer	0.000548	0.000868	CcSEcCtD
Labetalol—Discomfort—Paclitaxel—lung cancer	0.000548	0.000867	CcSEcCtD
Labetalol—Fatigue—Gemcitabine—lung cancer	0.000547	0.000866	CcSEcCtD
Labetalol—Confusional state—Etoposide—lung cancer	0.000546	0.000865	CcSEcCtD
Labetalol—Constipation—Gemcitabine—lung cancer	0.000543	0.000859	CcSEcCtD
Labetalol—Pain—Gemcitabine—lung cancer	0.000543	0.000859	CcSEcCtD
Labetalol—Nausea—Erlotinib—lung cancer	0.000543	0.000859	CcSEcCtD
Labetalol—Anaphylactic shock—Etoposide—lung cancer	0.000542	0.000858	CcSEcCtD
Labetalol—Mood swings—Doxorubicin—lung cancer	0.000542	0.000857	CcSEcCtD
Labetalol—Diarrhoea—Vinorelbine—lung cancer	0.00054	0.000855	CcSEcCtD
Labetalol—Feeling abnormal—Irinotecan—lung cancer	0.000537	0.00085	CcSEcCtD
Labetalol—Confusional state—Paclitaxel—lung cancer	0.000536	0.000848	CcSEcCtD
Labetalol—Dysuria—Methotrexate—lung cancer	0.000534	0.000845	CcSEcCtD
Labetalol—Gastrointestinal pain—Irinotecan—lung cancer	0.000533	0.000843	CcSEcCtD
Labetalol—Anaphylactic shock—Paclitaxel—lung cancer	0.000531	0.000841	CcSEcCtD
Labetalol—Oedema—Paclitaxel—lung cancer	0.000531	0.000841	CcSEcCtD
Labetalol—Paraesthesia—Cisplatin—lung cancer	0.000531	0.000841	CcSEcCtD
Labetalol—Muscle spasms—Docetaxel—lung cancer	0.00053	0.00084	CcSEcCtD
Labetalol—Liver function test abnormal—Doxorubicin—lung cancer	0.000528	0.000836	CcSEcCtD
Labetalol—Dyspnoea—Cisplatin—lung cancer	0.000527	0.000835	CcSEcCtD
Labetalol—Erectile dysfunction—Methotrexate—lung cancer	0.000526	0.000832	CcSEcCtD
Labetalol—Hyperhidrosis—Etoposide—lung cancer	0.000524	0.000829	CcSEcCtD
Labetalol—Feeling abnormal—Gemcitabine—lung cancer	0.000523	0.000828	CcSEcCtD
Labetalol—Shock—Paclitaxel—lung cancer	0.000523	0.000827	CcSEcCtD
Labetalol—Dizziness—Vinorelbine—lung cancer	0.000522	0.000827	CcSEcCtD
Labetalol—Orthostatic hypotension—Doxorubicin—lung cancer	0.000522	0.000827	CcSEcCtD
Labetalol—Abdominal pain upper—Doxorubicin—lung cancer	0.000522	0.000827	CcSEcCtD
Labetalol—Abdominal pain—Irinotecan—lung cancer	0.000515	0.000815	CcSEcCtD
Labetalol—Body temperature increased—Irinotecan—lung cancer	0.000515	0.000815	CcSEcCtD
Labetalol—Hyperhidrosis—Paclitaxel—lung cancer	0.000514	0.000813	CcSEcCtD
Labetalol—Drowsiness—Methotrexate—lung cancer	0.000509	0.000805	CcSEcCtD
Labetalol—Depression—Methotrexate—lung cancer	0.000507	0.000803	CcSEcCtD
Labetalol—Hypotension—Etoposide—lung cancer	0.000506	0.000801	CcSEcCtD
Labetalol—Pain—Cisplatin—lung cancer	0.000506	0.000801	CcSEcCtD
Labetalol—Vomiting—Vinorelbine—lung cancer	0.000502	0.000795	CcSEcCtD
Labetalol—Body temperature increased—Gemcitabine—lung cancer	0.000502	0.000794	CcSEcCtD
Labetalol—Rash—Vinorelbine—lung cancer	0.000498	0.000788	CcSEcCtD
Labetalol—Dermatitis—Vinorelbine—lung cancer	0.000498	0.000787	CcSEcCtD
Labetalol—Hypotension—Paclitaxel—lung cancer	0.000496	0.000786	CcSEcCtD
Labetalol—Headache—Vinorelbine—lung cancer	0.000495	0.000783	CcSEcCtD
Labetalol—Syncope—Docetaxel—lung cancer	0.000495	0.000783	CcSEcCtD
Labetalol—Sweating—Methotrexate—lung cancer	0.000488	0.000772	CcSEcCtD
Labetalol—Palpitations—Docetaxel—lung cancer	0.000488	0.000772	CcSEcCtD
Labetalol—Feeling abnormal—Cisplatin—lung cancer	0.000487	0.000771	CcSEcCtD
Labetalol—Paraesthesia—Etoposide—lung cancer	0.000487	0.00077	CcSEcCtD
Labetalol—Loss of consciousness—Docetaxel—lung cancer	0.000485	0.000768	CcSEcCtD
Labetalol—Dyspnoea—Etoposide—lung cancer	0.000483	0.000765	CcSEcCtD
Labetalol—Somnolence—Etoposide—lung cancer	0.000482	0.000762	CcSEcCtD
Labetalol—Angina pectoris—Doxorubicin—lung cancer	0.000481	0.000762	CcSEcCtD
Labetalol—Epistaxis—Methotrexate—lung cancer	0.00048	0.00076	CcSEcCtD
Labetalol—Hypersensitivity—Irinotecan—lung cancer	0.00048	0.00076	CcSEcCtD
Labetalol—Paraesthesia—Paclitaxel—lung cancer	0.000477	0.000755	CcSEcCtD
Labetalol—Hypertension—Docetaxel—lung cancer	0.000476	0.000754	CcSEcCtD
Labetalol—Agranulocytosis—Methotrexate—lung cancer	0.000475	0.000752	CcSEcCtD
Labetalol—Dyspnoea—Paclitaxel—lung cancer	0.000474	0.00075	CcSEcCtD
Labetalol—Somnolence—Paclitaxel—lung cancer	0.000472	0.000748	CcSEcCtD
Labetalol—Nausea—Vinorelbine—lung cancer	0.000469	0.000743	CcSEcCtD
Labetalol—Dyspepsia—Paclitaxel—lung cancer	0.000468	0.00074	CcSEcCtD
Labetalol—Body temperature increased—Cisplatin—lung cancer	0.000468	0.00074	CcSEcCtD
Labetalol—Asthenia—Irinotecan—lung cancer	0.000467	0.00074	CcSEcCtD
Labetalol—Fatigue—Etoposide—lung cancer	0.000467	0.000739	CcSEcCtD
Labetalol—Constipation—Etoposide—lung cancer	0.000463	0.000733	CcSEcCtD
Labetalol—Pain—Etoposide—lung cancer	0.000463	0.000733	CcSEcCtD
Labetalol—Dysuria—Doxorubicin—lung cancer	0.000462	0.000731	CcSEcCtD
Labetalol—Fatigue—Paclitaxel—lung cancer	0.000458	0.000725	CcSEcCtD
Labetalol—Hepatitis—Methotrexate—lung cancer	0.000457	0.000723	CcSEcCtD
Labetalol—Flurbiprofen—PTGS2—lung cancer	0.000456	0.0316	CrCbGaD
Labetalol—Asthenia—Gemcitabine—lung cancer	0.000455	0.000721	CcSEcCtD
Labetalol—Constipation—Paclitaxel—lung cancer	0.000454	0.000719	CcSEcCtD
Labetalol—Pain—Paclitaxel—lung cancer	0.000454	0.000719	CcSEcCtD
Labetalol—Confusional state—Docetaxel—lung cancer	0.000454	0.000719	CcSEcCtD
Labetalol—Anaphylactic shock—Docetaxel—lung cancer	0.00045	0.000713	CcSEcCtD
Labetalol—Oedema—Docetaxel—lung cancer	0.00045	0.000713	CcSEcCtD
Labetalol—Pruritus—Gemcitabine—lung cancer	0.000449	0.000711	CcSEcCtD
Labetalol—Feeling abnormal—Etoposide—lung cancer	0.000446	0.000707	CcSEcCtD
Labetalol—Diarrhoea—Irinotecan—lung cancer	0.000446	0.000705	CcSEcCtD
Labetalol—Propafenone—ABCB1—lung cancer	0.000444	0.0308	CrCbGaD
Labetalol—Gastrointestinal pain—Etoposide—lung cancer	0.000443	0.000701	CcSEcCtD
Labetalol—Shock—Docetaxel—lung cancer	0.000443	0.000701	CcSEcCtD
Labetalol—Drowsiness—Doxorubicin—lung cancer	0.000441	0.000697	CcSEcCtD
Labetalol—Visual impairment—Methotrexate—lung cancer	0.00044	0.000697	CcSEcCtD
Labetalol—Feeling abnormal—Paclitaxel—lung cancer	0.000438	0.000693	CcSEcCtD
Labetalol—Hypersensitivity—Cisplatin—lung cancer	0.000436	0.00069	CcSEcCtD
Labetalol—Gastrointestinal pain—Paclitaxel—lung cancer	0.000434	0.000688	CcSEcCtD
Labetalol—Diarrhoea—Gemcitabine—lung cancer	0.000434	0.000687	CcSEcCtD
Labetalol—Dizziness—Irinotecan—lung cancer	0.000431	0.000682	CcSEcCtD
Labetalol—Urticaria—Etoposide—lung cancer	0.00043	0.000681	CcSEcCtD
Labetalol—Jaundice—Doxorubicin—lung cancer	0.000429	0.00068	CcSEcCtD
Labetalol—Abdominal pain—Etoposide—lung cancer	0.000428	0.000678	CcSEcCtD
Labetalol—Body temperature increased—Etoposide—lung cancer	0.000428	0.000678	CcSEcCtD
Labetalol—Asthenia—Cisplatin—lung cancer	0.000424	0.000672	CcSEcCtD
Labetalol—Sweating—Doxorubicin—lung cancer	0.000422	0.000669	CcSEcCtD
Labetalol—Urticaria—Paclitaxel—lung cancer	0.000422	0.000668	CcSEcCtD
Labetalol—Hypotension—Docetaxel—lung cancer	0.000421	0.000666	CcSEcCtD
Labetalol—Abdominal pain—Paclitaxel—lung cancer	0.00042	0.000665	CcSEcCtD
Labetalol—Body temperature increased—Paclitaxel—lung cancer	0.00042	0.000665	CcSEcCtD
Labetalol—Epistaxis—Doxorubicin—lung cancer	0.000416	0.000658	CcSEcCtD
Labetalol—Vomiting—Irinotecan—lung cancer	0.000414	0.000656	CcSEcCtD
Labetalol—Ketoprofen—PTGS2—lung cancer	0.000412	0.0286	CrCbGaD
Labetalol—Agranulocytosis—Doxorubicin—lung cancer	0.000411	0.000651	CcSEcCtD
Labetalol—Rash—Irinotecan—lung cancer	0.000411	0.00065	CcSEcCtD
Labetalol—Dermatitis—Irinotecan—lung cancer	0.00041	0.000649	CcSEcCtD
Labetalol—Headache—Irinotecan—lung cancer	0.000408	0.000646	CcSEcCtD
Labetalol—Flurbiprofen—ALB—lung cancer	0.000406	0.0281	CrCbGaD
Labetalol—Diarrhoea—Cisplatin—lung cancer	0.000405	0.00064	CcSEcCtD
Labetalol—Paraesthesia—Docetaxel—lung cancer	0.000404	0.00064	CcSEcCtD
Labetalol—Alopecia—Methotrexate—lung cancer	0.000404	0.000639	CcSEcCtD
Labetalol—Vomiting—Gemcitabine—lung cancer	0.000403	0.000639	CcSEcCtD
Labetalol—Bradycardia—Doxorubicin—lung cancer	0.000403	0.000637	CcSEcCtD
Labetalol—Dyspnoea—Docetaxel—lung cancer	0.000401	0.000635	CcSEcCtD
Labetalol—Somnolence—Docetaxel—lung cancer	0.0004	0.000634	CcSEcCtD
Labetalol—Mental disorder—Methotrexate—lung cancer	0.0004	0.000633	CcSEcCtD
Labetalol—Rash—Gemcitabine—lung cancer	0.0004	0.000633	CcSEcCtD
Labetalol—Dermatitis—Gemcitabine—lung cancer	0.0004	0.000633	CcSEcCtD
Labetalol—Hypersensitivity—Etoposide—lung cancer	0.000399	0.000632	CcSEcCtD
Labetalol—Erythema—Methotrexate—lung cancer	0.000398	0.000629	CcSEcCtD
Labetalol—Headache—Gemcitabine—lung cancer	0.000397	0.000629	CcSEcCtD
Labetalol—Dyspepsia—Docetaxel—lung cancer	0.000396	0.000627	CcSEcCtD
Labetalol—Hepatitis—Doxorubicin—lung cancer	0.000396	0.000626	CcSEcCtD
Labetalol—Hypoaesthesia—Doxorubicin—lung cancer	0.000394	0.000623	CcSEcCtD
Labetalol—Hypersensitivity—Paclitaxel—lung cancer	0.000391	0.00062	CcSEcCtD
Labetalol—Oedema peripheral—Doxorubicin—lung cancer	0.00039	0.000617	CcSEcCtD
Labetalol—Asthenia—Etoposide—lung cancer	0.000389	0.000615	CcSEcCtD
Labetalol—Fatigue—Docetaxel—lung cancer	0.000388	0.000614	CcSEcCtD
Labetalol—Nausea—Irinotecan—lung cancer	0.000387	0.000612	CcSEcCtD
Labetalol—Pain—Docetaxel—lung cancer	0.000385	0.000609	CcSEcCtD
Labetalol—Constipation—Docetaxel—lung cancer	0.000385	0.000609	CcSEcCtD
Labetalol—Pruritus—Etoposide—lung cancer	0.000383	0.000607	CcSEcCtD
Labetalol—Visual impairment—Doxorubicin—lung cancer	0.000381	0.000603	CcSEcCtD
Labetalol—Asthenia—Paclitaxel—lung cancer	0.000381	0.000603	CcSEcCtD
Labetalol—Nausea—Gemcitabine—lung cancer	0.000377	0.000597	CcSEcCtD
Labetalol—Vomiting—Cisplatin—lung cancer	0.000376	0.000595	CcSEcCtD
Labetalol—Pruritus—Paclitaxel—lung cancer	0.000376	0.000595	CcSEcCtD
Labetalol—Vision blurred—Methotrexate—lung cancer	0.000375	0.000593	CcSEcCtD
Labetalol—Rash—Cisplatin—lung cancer	0.000373	0.00059	CcSEcCtD
Labetalol—Dermatitis—Cisplatin—lung cancer	0.000373	0.00059	CcSEcCtD
Labetalol—Feeling abnormal—Docetaxel—lung cancer	0.000371	0.000587	CcSEcCtD
Labetalol—Diarrhoea—Etoposide—lung cancer	0.000371	0.000587	CcSEcCtD
Labetalol—Ill-defined disorder—Methotrexate—lung cancer	0.000369	0.000584	CcSEcCtD
Labetalol—Gastrointestinal pain—Docetaxel—lung cancer	0.000368	0.000583	CcSEcCtD
Labetalol—Ketoprofen—ALB—lung cancer	0.000367	0.0255	CrCbGaD
Labetalol—Flushing—Doxorubicin—lung cancer	0.000367	0.000581	CcSEcCtD
Labetalol—Diarrhoea—Paclitaxel—lung cancer	0.000363	0.000575	CcSEcCtD
Labetalol—Malaise—Methotrexate—lung cancer	0.000359	0.000568	CcSEcCtD
Labetalol—Dizziness—Etoposide—lung cancer	0.000358	0.000567	CcSEcCtD
Labetalol—Vertigo—Methotrexate—lung cancer	0.000357	0.000565	CcSEcCtD
Labetalol—Abdominal pain—Docetaxel—lung cancer	0.000356	0.000563	CcSEcCtD
Labetalol—Body temperature increased—Docetaxel—lung cancer	0.000356	0.000563	CcSEcCtD
Labetalol—Dizziness—Paclitaxel—lung cancer	0.000351	0.000556	CcSEcCtD
Labetalol—Nausea—Cisplatin—lung cancer	0.000351	0.000556	CcSEcCtD
Labetalol—Alopecia—Doxorubicin—lung cancer	0.00035	0.000553	CcSEcCtD
Labetalol—Mental disorder—Doxorubicin—lung cancer	0.000347	0.000549	CcSEcCtD
Labetalol—Vomiting—Etoposide—lung cancer	0.000344	0.000545	CcSEcCtD
Labetalol—Erythema—Doxorubicin—lung cancer	0.000344	0.000545	CcSEcCtD
Labetalol—Rash—Etoposide—lung cancer	0.000342	0.000541	CcSEcCtD
Labetalol—Dermatitis—Etoposide—lung cancer	0.000341	0.00054	CcSEcCtD
Labetalol—Headache—Etoposide—lung cancer	0.000339	0.000537	CcSEcCtD
Labetalol—Vomiting—Paclitaxel—lung cancer	0.000338	0.000535	CcSEcCtD
Labetalol—Rash—Paclitaxel—lung cancer	0.000335	0.00053	CcSEcCtD
Labetalol—Dermatitis—Paclitaxel—lung cancer	0.000335	0.00053	CcSEcCtD
Labetalol—Discomfort—Methotrexate—lung cancer	0.000334	0.000529	CcSEcCtD
Labetalol—Headache—Paclitaxel—lung cancer	0.000333	0.000527	CcSEcCtD
Labetalol—Hypersensitivity—Docetaxel—lung cancer	0.000332	0.000525	CcSEcCtD
Labetalol—Muscle spasms—Doxorubicin—lung cancer	0.000331	0.000524	CcSEcCtD
Labetalol—Confusional state—Methotrexate—lung cancer	0.000327	0.000518	CcSEcCtD
Labetalol—Anaphylactic shock—Methotrexate—lung cancer	0.000325	0.000514	CcSEcCtD
Labetalol—Vision blurred—Doxorubicin—lung cancer	0.000325	0.000514	CcSEcCtD
Labetalol—Asthenia—Docetaxel—lung cancer	0.000323	0.000511	CcSEcCtD
Labetalol—Nausea—Etoposide—lung cancer	0.000322	0.000509	CcSEcCtD
Labetalol—Ill-defined disorder—Doxorubicin—lung cancer	0.000319	0.000506	CcSEcCtD
Labetalol—Pruritus—Docetaxel—lung cancer	0.000319	0.000504	CcSEcCtD
Labetalol—Nausea—Paclitaxel—lung cancer	0.000316	0.000499	CcSEcCtD
Labetalol—Hyperhidrosis—Methotrexate—lung cancer	0.000314	0.000497	CcSEcCtD
Labetalol—Malaise—Doxorubicin—lung cancer	0.000311	0.000491	CcSEcCtD
Labetalol—Vertigo—Doxorubicin—lung cancer	0.000309	0.00049	CcSEcCtD
Labetalol—Syncope—Doxorubicin—lung cancer	0.000309	0.000489	CcSEcCtD
Labetalol—Diarrhoea—Docetaxel—lung cancer	0.000308	0.000488	CcSEcCtD
Labetalol—Palpitations—Doxorubicin—lung cancer	0.000304	0.000482	CcSEcCtD
Labetalol—Hypotension—Methotrexate—lung cancer	0.000303	0.00048	CcSEcCtD
Labetalol—Loss of consciousness—Doxorubicin—lung cancer	0.000303	0.000479	CcSEcCtD
Labetalol—Dizziness—Docetaxel—lung cancer	0.000298	0.000471	CcSEcCtD
Labetalol—Hypertension—Doxorubicin—lung cancer	0.000297	0.000471	CcSEcCtD
Labetalol—Paraesthesia—Methotrexate—lung cancer	0.000291	0.000461	CcSEcCtD
Labetalol—Discomfort—Doxorubicin—lung cancer	0.00029	0.000458	CcSEcCtD
Labetalol—Dyspnoea—Methotrexate—lung cancer	0.000289	0.000458	CcSEcCtD
Labetalol—Somnolence—Methotrexate—lung cancer	0.000289	0.000457	CcSEcCtD
Labetalol—Vomiting—Docetaxel—lung cancer	0.000286	0.000453	CcSEcCtD
Labetalol—Dyspepsia—Methotrexate—lung cancer	0.000286	0.000452	CcSEcCtD
Labetalol—Rash—Docetaxel—lung cancer	0.000284	0.000449	CcSEcCtD
Labetalol—Dermatitis—Docetaxel—lung cancer	0.000284	0.000449	CcSEcCtD
Labetalol—Confusional state—Doxorubicin—lung cancer	0.000283	0.000448	CcSEcCtD
Labetalol—Headache—Docetaxel—lung cancer	0.000282	0.000446	CcSEcCtD
Labetalol—Anaphylactic shock—Doxorubicin—lung cancer	0.000281	0.000445	CcSEcCtD
Labetalol—Oedema—Doxorubicin—lung cancer	0.000281	0.000445	CcSEcCtD
Labetalol—Fatigue—Methotrexate—lung cancer	0.00028	0.000443	CcSEcCtD
Labetalol—Pain—Methotrexate—lung cancer	0.000278	0.000439	CcSEcCtD
Labetalol—Shock—Doxorubicin—lung cancer	0.000276	0.000438	CcSEcCtD
Labetalol—Hyperhidrosis—Doxorubicin—lung cancer	0.000272	0.00043	CcSEcCtD
Labetalol—Nausea—Docetaxel—lung cancer	0.000267	0.000423	CcSEcCtD
Labetalol—Feeling abnormal—Methotrexate—lung cancer	0.000267	0.000423	CcSEcCtD
Labetalol—Gastrointestinal pain—Methotrexate—lung cancer	0.000265	0.00042	CcSEcCtD
Labetalol—Hypotension—Doxorubicin—lung cancer	0.000263	0.000416	CcSEcCtD
Labetalol—Urticaria—Methotrexate—lung cancer	0.000258	0.000408	CcSEcCtD
Labetalol—Abdominal pain—Methotrexate—lung cancer	0.000257	0.000406	CcSEcCtD
Labetalol—Body temperature increased—Methotrexate—lung cancer	0.000257	0.000406	CcSEcCtD
Labetalol—Paraesthesia—Doxorubicin—lung cancer	0.000252	0.000399	CcSEcCtD
Labetalol—Dyspnoea—Doxorubicin—lung cancer	0.000251	0.000397	CcSEcCtD
Labetalol—Somnolence—Doxorubicin—lung cancer	0.00025	0.000395	CcSEcCtD
Labetalol—Dyspepsia—Doxorubicin—lung cancer	0.000247	0.000392	CcSEcCtD
Labetalol—Fatigue—Doxorubicin—lung cancer	0.000242	0.000383	CcSEcCtD
Labetalol—Pain—Doxorubicin—lung cancer	0.00024	0.00038	CcSEcCtD
Labetalol—Constipation—Doxorubicin—lung cancer	0.00024	0.00038	CcSEcCtD
Labetalol—Hypersensitivity—Methotrexate—lung cancer	0.000239	0.000378	CcSEcCtD
Labetalol—Asthenia—Methotrexate—lung cancer	0.000233	0.000369	CcSEcCtD
Labetalol—Feeling abnormal—Doxorubicin—lung cancer	0.000232	0.000367	CcSEcCtD
Labetalol—Gastrointestinal pain—Doxorubicin—lung cancer	0.00023	0.000364	CcSEcCtD
Labetalol—Pruritus—Methotrexate—lung cancer	0.00023	0.000363	CcSEcCtD
Labetalol—Urticaria—Doxorubicin—lung cancer	0.000223	0.000353	CcSEcCtD
Labetalol—Abdominal pain—Doxorubicin—lung cancer	0.000222	0.000352	CcSEcCtD
Labetalol—Body temperature increased—Doxorubicin—lung cancer	0.000222	0.000352	CcSEcCtD
Labetalol—Diarrhoea—Methotrexate—lung cancer	0.000222	0.000351	CcSEcCtD
Labetalol—Dizziness—Methotrexate—lung cancer	0.000215	0.00034	CcSEcCtD
Labetalol—Hypersensitivity—Doxorubicin—lung cancer	0.000207	0.000328	CcSEcCtD
Labetalol—Vomiting—Methotrexate—lung cancer	0.000206	0.000327	CcSEcCtD
Labetalol—Rash—Methotrexate—lung cancer	0.000205	0.000324	CcSEcCtD
Labetalol—Dermatitis—Methotrexate—lung cancer	0.000204	0.000324	CcSEcCtD
Labetalol—Headache—Methotrexate—lung cancer	0.000203	0.000322	CcSEcCtD
Labetalol—Asthenia—Doxorubicin—lung cancer	0.000202	0.000319	CcSEcCtD
Labetalol—Pruritus—Doxorubicin—lung cancer	0.000199	0.000315	CcSEcCtD
Labetalol—Nausea—Methotrexate—lung cancer	0.000193	0.000305	CcSEcCtD
Labetalol—Diarrhoea—Doxorubicin—lung cancer	0.000192	0.000304	CcSEcCtD
Labetalol—Dizziness—Doxorubicin—lung cancer	0.000186	0.000294	CcSEcCtD
Labetalol—Vomiting—Doxorubicin—lung cancer	0.000179	0.000283	CcSEcCtD
Labetalol—Rash—Doxorubicin—lung cancer	0.000177	0.00028	CcSEcCtD
Labetalol—Dermatitis—Doxorubicin—lung cancer	0.000177	0.00028	CcSEcCtD
Labetalol—Headache—Doxorubicin—lung cancer	0.000176	0.000279	CcSEcCtD
Labetalol—Nausea—Doxorubicin—lung cancer	0.000167	0.000264	CcSEcCtD
Labetalol—ADRB3—Signaling Pathways—HIF1A—lung cancer	5.04e-05	0.000504	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ANXA1—lung cancer	5.01e-05	0.000501	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—FLT1—lung cancer	4.96e-05	0.000496	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GSTA3—lung cancer	4.95e-05	0.000495	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—RRM1—lung cancer	4.95e-05	0.000495	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PIK3CG—lung cancer	4.91e-05	0.000491	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—APOA1—lung cancer	4.86e-05	0.000487	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APP—lung cancer	4.86e-05	0.000486	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NOTCH3—lung cancer	4.86e-05	0.000486	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—FLT1—lung cancer	4.85e-05	0.000485	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—KDR—lung cancer	4.82e-05	0.000482	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—FGF9—lung cancer	4.82e-05	0.000482	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PIK3CG—lung cancer	4.81e-05	0.000481	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APP—lung cancer	4.75e-05	0.000475	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NOTCH3—lung cancer	4.75e-05	0.000475	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—FGF9—lung cancer	4.71e-05	0.000471	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—POMC—lung cancer	4.68e-05	0.000468	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—B4GALT5—lung cancer	4.66e-05	0.000466	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—JUNB—lung cancer	4.6e-05	0.00046	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—POMC—lung cancer	4.58e-05	0.000458	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GSTA4—lung cancer	4.53e-05	0.000453	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—JUNB—lung cancer	4.5e-05	0.00045	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PIK3CG—lung cancer	4.46e-05	0.000446	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—APC—lung cancer	4.44e-05	0.000444	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PIK3CG—lung cancer	4.44e-05	0.000444	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—KIT—lung cancer	4.44e-05	0.000444	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—NRAS—lung cancer	4.44e-05	0.000444	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GSTA2—lung cancer	4.41e-05	0.000441	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—EGF—lung cancer	4.39e-05	0.000439	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PIK3CG—lung cancer	4.37e-05	0.000437	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PIK3CD—lung cancer	4.32e-05	0.000432	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GSTA1—lung cancer	4.26e-05	0.000426	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—MAPK3—lung cancer	4.25e-05	0.000425	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—POMC—lung cancer	4.25e-05	0.000425	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—POMC—lung cancer	4.23e-05	0.000423	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PIK3CD—lung cancer	4.23e-05	0.000423	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ABCC3—lung cancer	4.21e-05	0.000421	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—STK11—lung cancer	4.18e-05	0.000418	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—BRAF—lung cancer	4.17e-05	0.000417	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—POMC—lung cancer	4.16e-05	0.000416	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—IL6R—lung cancer	4.14e-05	0.000414	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IL6R—lung cancer	4.12e-05	0.000412	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CREBBP—lung cancer	4.12e-05	0.000412	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—STK11—lung cancer	4.08e-05	0.000408	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—AKR1C1—lung cancer	4.08e-05	0.000408	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—IL6R—lung cancer	4.05e-05	0.000405	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—EGFR—lung cancer	4.05e-05	0.000405	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—FOXO3—lung cancer	4.03e-05	0.000403	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—UGT1A1—lung cancer	3.96e-05	0.000396	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—MAP2K1—lung cancer	3.95e-05	0.000395	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—FOXO3—lung cancer	3.94e-05	0.000394	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MAP2K1—lung cancer	3.93e-05	0.000393	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PIK3CD—lung cancer	3.92e-05	0.000392	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PIK3CD—lung cancer	3.9e-05	0.00039	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—PIK3CA—lung cancer	3.87e-05	0.000387	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—MAP2K1—lung cancer	3.86e-05	0.000386	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PIK3CD—lung cancer	3.84e-05	0.000384	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—KRAS—lung cancer	3.82e-05	0.000382	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GNG11—lung cancer	3.82e-05	0.000382	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AVP—lung cancer	3.78e-05	0.000378	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PIK3CB—lung cancer	3.77e-05	0.000377	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AVP—lung cancer	3.69e-05	0.000369	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PIK3CB—lung cancer	3.68e-05	0.000368	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ALDOA—lung cancer	3.64e-05	0.000364	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IGF1R—lung cancer	3.63e-05	0.000363	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CXCL8—lung cancer	3.62e-05	0.000362	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HES1—lung cancer	3.57e-05	0.000357	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IGF1R—lung cancer	3.56e-05	0.000356	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CXCL8—lung cancer	3.54e-05	0.000354	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—NCOA3—lung cancer	3.53e-05	0.000353	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—PIK3CA—lung cancer	3.51e-05	0.000351	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—RAF1—lung cancer	3.5e-05	0.00035	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MDM2—lung cancer	3.5e-05	0.00035	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HES1—lung cancer	3.49e-05	0.000349	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—RAF1—lung cancer	3.49e-05	0.000349	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—IL2—lung cancer	3.46e-05	0.000346	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—ERBB2—lung cancer	3.45e-05	0.000345	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ADCY1—lung cancer	3.43e-05	0.000343	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ABCG2—lung cancer	3.43e-05	0.000343	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—RAF1—lung cancer	3.43e-05	0.000343	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PIK3CB—lung cancer	3.42e-05	0.000342	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PIK3CB—lung cancer	3.4e-05	0.00034	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MTOR—lung cancer	3.4e-05	0.00034	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—IL2—lung cancer	3.38e-05	0.000338	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ENO2—lung cancer	3.37e-05	0.000337	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—HPGDS—lung cancer	3.37e-05	0.000337	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PPP2R1B—lung cancer	3.35e-05	0.000335	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PIK3CB—lung cancer	3.34e-05	0.000334	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CXCL8—lung cancer	3.29e-05	0.000329	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CXCL8—lung cancer	3.27e-05	0.000327	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GSTT1—lung cancer	3.27e-05	0.000327	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ERBB3—lung cancer	3.26e-05	0.000326	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—HRAS—lung cancer	3.25e-05	0.000325	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GCLC—lung cancer	3.23e-05	0.000323	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYP2A6—lung cancer	3.23e-05	0.000323	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CXCL8—lung cancer	3.21e-05	0.000321	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ERBB3—lung cancer	3.19e-05	0.000319	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—AKT1—lung cancer	3.16e-05	0.000316	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—IL2—lung cancer	3.14e-05	0.000314	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CASP3—lung cancer	3.13e-05	0.000313	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TERT—lung cancer	3.13e-05	0.000313	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IL2—lung cancer	3.13e-05	0.000313	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—IL6—lung cancer	3.11e-05	0.000311	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—IL2—lung cancer	3.07e-05	0.000307	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TERT—lung cancer	3.06e-05	0.000306	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ENO1—lung cancer	3.06e-05	0.000306	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CCND1—lung cancer	3.05e-05	0.000305	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—JUN—lung cancer	3.04e-05	0.000304	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—FGFR1—lung cancer	3.04e-05	0.000304	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HIF1A—lung cancer	2.99e-05	0.000299	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—FGFR1—lung cancer	2.97e-05	0.000297	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MMP9—lung cancer	2.96e-05	0.000296	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CDKN1A—lung cancer	2.95e-05	0.000295	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PTEN—lung cancer	2.94e-05	0.000294	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HIF1A—lung cancer	2.93e-05	0.000293	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APOA1—lung cancer	2.89e-05	0.000289	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—AKT1—lung cancer	2.87e-05	0.000287	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—KDR—lung cancer	2.86e-05	0.000286	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APOA1—lung cancer	2.82e-05	0.000282	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—EP300—lung cancer	2.8e-05	0.00028	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—KDR—lung cancer	2.8e-05	0.00028	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYP2E1—lung cancer	2.74e-05	0.000274	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—SRC—lung cancer	2.73e-05	0.000273	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—NQO1—lung cancer	2.71e-05	0.000271	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—VEGFA—lung cancer	2.66e-05	0.000266	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APC—lung cancer	2.64e-05	0.000264	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PIK3CG—lung cancer	2.64e-05	0.000264	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—KIT—lung cancer	2.64e-05	0.000264	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—NRAS—lung cancer	2.64e-05	0.000264	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—STAT3—lung cancer	2.63e-05	0.000263	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NRAS—lung cancer	2.62e-05	0.000262	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—EGF—lung cancer	2.61e-05	0.000261	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—KIT—lung cancer	2.58e-05	0.000258	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APC—lung cancer	2.58e-05	0.000258	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PIK3CG—lung cancer	2.58e-05	0.000258	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—NRAS—lung cancer	2.58e-05	0.000258	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—EGF—lung cancer	2.55e-05	0.000255	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—MAPK3—lung cancer	2.52e-05	0.000252	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MAPK3—lung cancer	2.51e-05	0.000251	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—POMC—lung cancer	2.51e-05	0.000251	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—BRAF—lung cancer	2.48e-05	0.000248	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—MAPK3—lung cancer	2.47e-05	0.000247	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—POMC—lung cancer	2.45e-05	0.000245	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IL6R—lung cancer	2.45e-05	0.000245	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—STK11—lung cancer	2.45e-05	0.000245	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CREBBP—lung cancer	2.44e-05	0.000244	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MYC—lung cancer	2.44e-05	0.000244	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—BRAF—lung cancer	2.42e-05	0.000242	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—EGFR—lung cancer	2.4e-05	0.00024	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IL6R—lung cancer	2.39e-05	0.000239	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CREBBP—lung cancer	2.39e-05	0.000239	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—EGFR—lung cancer	2.39e-05	0.000239	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—EGFR—lung cancer	2.35e-05	0.000235	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MAP2K1—lung cancer	2.33e-05	0.000233	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PIK3CD—lung cancer	2.32e-05	0.000232	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PIK3CA—lung cancer	2.3e-05	0.00023	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MAP2K1—lung cancer	2.28e-05	0.000228	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—KRAS—lung cancer	2.27e-05	0.000227	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PIK3CD—lung cancer	2.27e-05	0.000227	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GSTP1—lung cancer	2.26e-05	0.000226	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—KRAS—lung cancer	2.26e-05	0.000226	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PIK3CA—lung cancer	2.25e-05	0.000225	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—KRAS—lung cancer	2.22e-05	0.000222	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CAT—lung cancer	2.2e-05	0.00022	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ABCB1—lung cancer	2.14e-05	0.000214	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—TYMS—lung cancer	2.1e-05	0.00021	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PIK3CA—lung cancer	2.08e-05	0.000208	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GSTM1—lung cancer	2.08e-05	0.000208	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MDM2—lung cancer	2.08e-05	0.000208	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PIK3CA—lung cancer	2.07e-05	0.000207	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—RAF1—lung cancer	2.07e-05	0.000207	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ERBB2—lung cancer	2.05e-05	0.000205	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PIK3CA—lung cancer	2.04e-05	0.000204	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MDM2—lung cancer	2.03e-05	0.000203	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—RAF1—lung cancer	2.02e-05	0.000202	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MTOR—lung cancer	2.02e-05	0.000202	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PIK3CB—lung cancer	2.02e-05	0.000202	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—TP53—lung cancer	2.01e-05	0.000201	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ERBB2—lung cancer	2e-05	0.0002	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PIK3CB—lung cancer	1.98e-05	0.000198	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MTOR—lung cancer	1.98e-05	0.000198	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYP1A1—lung cancer	1.97e-05	0.000197	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ERCC2—lung cancer	1.96e-05	0.000196	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CXCL8—lung cancer	1.94e-05	0.000194	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—HRAS—lung cancer	1.93e-05	0.000193	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HRAS—lung cancer	1.92e-05	0.000192	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CXCL8—lung cancer	1.9e-05	0.00019	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—HRAS—lung cancer	1.89e-05	0.000189	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—AKT1—lung cancer	1.88e-05	0.000188	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CASP3—lung cancer	1.86e-05	0.000186	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IL2—lung cancer	1.86e-05	0.000186	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—IL6—lung cancer	1.85e-05	0.000185	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IL6—lung cancer	1.84e-05	0.000184	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—AKT1—lung cancer	1.83e-05	0.000183	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CASP3—lung cancer	1.82e-05	0.000182	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IL2—lung cancer	1.81e-05	0.000181	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCND1—lung cancer	1.81e-05	0.000181	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—IL6—lung cancer	1.81e-05	0.000181	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—JUN—lung cancer	1.8e-05	0.00018	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCND1—lung cancer	1.77e-05	0.000177	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—JUN—lung cancer	1.77e-05	0.000177	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MMP9—lung cancer	1.76e-05	0.000176	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CDKN1A—lung cancer	1.75e-05	0.000175	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PTEN—lung cancer	1.75e-05	0.000175	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MMP9—lung cancer	1.72e-05	0.000172	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CDKN1A—lung cancer	1.71e-05	0.000171	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PTEN—lung cancer	1.71e-05	0.000171	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—AKT1—lung cancer	1.7e-05	0.00017	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—AKT1—lung cancer	1.69e-05	0.000169	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOA1—lung cancer	1.69e-05	0.000169	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—AKT1—lung cancer	1.67e-05	0.000167	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—EP300—lung cancer	1.66e-05	0.000166	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—EP300—lung cancer	1.63e-05	0.000163	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SRC—lung cancer	1.62e-05	0.000162	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SRC—lung cancer	1.58e-05	0.000158	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—VEGFA—lung cancer	1.58e-05	0.000158	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—STAT3—lung cancer	1.56e-05	0.000156	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NRAS—lung cancer	1.56e-05	0.000156	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PIK3CG—lung cancer	1.54e-05	0.000154	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—VEGFA—lung cancer	1.54e-05	0.000154	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—STAT3—lung cancer	1.53e-05	0.000153	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NRAS—lung cancer	1.52e-05	0.000152	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MAPK3—lung cancer	1.49e-05	0.000149	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—POMC—lung cancer	1.47e-05	0.000147	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MAPK3—lung cancer	1.46e-05	0.000146	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MYC—lung cancer	1.45e-05	0.000145	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CREBBP—lung cancer	1.43e-05	0.000143	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MYC—lung cancer	1.42e-05	0.000142	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—EGFR—lung cancer	1.42e-05	0.000142	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—EGFR—lung cancer	1.39e-05	0.000139	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PIK3CD—lung cancer	1.36e-05	0.000136	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—KRAS—lung cancer	1.34e-05	0.000134	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ALB—lung cancer	1.34e-05	0.000134	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—KRAS—lung cancer	1.31e-05	0.000131	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PIK3CA—lung cancer	1.23e-05	0.000123	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PIK3CA—lung cancer	1.2e-05	0.00012	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TP53—lung cancer	1.19e-05	0.000119	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PIK3CB—lung cancer	1.18e-05	0.000118	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PTGS2—lung cancer	1.17e-05	0.000117	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TP53—lung cancer	1.17e-05	0.000117	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HRAS—lung cancer	1.14e-05	0.000114	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HRAS—lung cancer	1.11e-05	0.000111	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IL6—lung cancer	1.09e-05	0.000109	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IL6—lung cancer	1.07e-05	0.000107	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PTEN—lung cancer	1.02e-05	0.000102	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AKT1—lung cancer	1.01e-05	0.000101	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AKT1—lung cancer	9.84e-06	9.84e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—EP300—lung cancer	9.75e-06	9.75e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PIK3CA—lung cancer	7.21e-06	7.21e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—AKT1—lung cancer	5.89e-06	5.89e-05	CbGpPWpGaD
